Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-25-035578
Filing Date
2025-04-25
Accepted
2025-04-25 16:15:13
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0239331-10ka1_180life.htm   iXBRL 10-K/A 481263
2 CERTIFICATION ea023933101ex31-3_180life.htm EX-31.3 3062
3 CERTIFICATION ea023933101ex31-4_180life.htm EX-31.4 3070
4 GRAPHIC image_001.jpg GRAPHIC 15551
  Complete submission text file 0001213900-25-035578.txt   859436

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20241231.xsd EX-101.SCH 3759
6 XBRL DEFINITION FILE atnf-20241231_def.xml EX-101.DEF 17284
7 XBRL LABEL FILE atnf-20241231_lab.xml EX-101.LAB 36841
8 XBRL PRESENTATION FILE atnf-20241231_pre.xml EX-101.PRE 19048
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0239331-10ka1_180life_htm.xml XML 11502
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38105 | Film No.: 25874220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)